[HTML][HTML] The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use

PY Perera, JH Lichy, TA Waldmann, LP Perera - Microbes and Infection, 2012 - Elsevier
Interleukin-15 (IL-15) is a pleiotropic cytokine with a broad range of biological functions in
many diverse cell types. It plays a major role in the development of inflammatory and …

TLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages

V Toshchakov, BW Jones, PY Perera, K Thomas… - Nature …, 2002 - nature.com
Toll-like receptor 2 (TLR2) agonists induce a subset of TLR4-inducible proinflammatory
genes, which suggests the use of differential signaling pathways. Murine macrophages …

CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression

PY Perera, TN Mayadas, O Takeuchi… - The Journal of …, 2001 - journals.aai.org
Overproduction of inflammatory mediators by macrophages in response to Gram-negative
LPS has been implicated in septic shock. Recent reports indicate that three membrane-…

CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or …

PY Perera, SN Vogel, GR Detore, A Haziot… - Journal of immunology …, 1997 - journals.aai.org
The antitumor agent, Taxol, shares with bacterial LPS the ability to activate murine macrophages,
and its LPS-mimetic effects are blocked by LPS analogue antagonists. Since CD14 is …

Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes

…, N Watanabe, N Sato, PY Perera… - Proceedings of the …, 2009 - National Acad Sciences
Celiac disease (CD) is an autoimmune inflammatory disease with a relatively high prevalence
especially in the western hemisphere. A strong genetic component is involved in the …

The chemotherapeutic agent DMXAA potently and specifically activates the TBK1–IRF-3 signaling axis

ZJ Roberts, N Goutagny, PY Perera, H Kato… - The Journal of …, 2007 - rupress.org
Vascular disrupting agents (VDAs) represent a novel approach to the treatment of cancer,
resulting in the collapse of tumor vasculature and tumor death. 5,6-dimethylxanthenone-4-…

Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T‐cell malignancies

…, ME Kadin, TA Waldmann, PY Perera - American journal of …, 2017 - Wiley Online Library
With the emerging success of treating CD19 expressing B cell malignancies with ex vivo
modified, autologous T cells that express CD19‐directed chimeric antigen receptors (CAR), …

Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages.

CL Manthey, ME Brandes, PY Perera… - Journal of immunology …, 1992 - journals.aai.org
Taxol, a microtubule stabilizing agent, exhibits promise in the treatment of breast and ovarian
tumors. Recently, this novel drug has been shown to activate murine macrophages to …

Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease

…, PY Perera, TA Waldmann, T Hiroi, LP Perera - Journal of clinical …, 2013 - Springer
… LP Perera gratefully acknowledges the receipt of an invitational fellowship from the
Japan Society for the Promotion of Science. … Pin-Yu Perera … Pin-Yu Perera

Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation

SN Vogel, D Johnson, PY Perera… - The Journal of …, 1999 - journals.aai.org
A point mutation in the Tlr4 gene, which encodes Toll-like receptor 4, has recently been
proposed to underlie LPS hyporesponsiveness in C3H/HeJ mice (Lps d). The data presented …